Author: Leslie Gibson McCarthy

Images from in and around the Washington University campuses.

Citing their wish to expand arts and education opportunities, leading local arts patrons Kenneth and Nancy Kranzberg have expressed their intention to make a $2 million gift to Washington University in St. Louis.

Faculty, staff and students are encouraged to volunteer to help with the annual Commencement ceremony Friday, May 20. From ushering guests and graduates to passing out programs and other duties, volunteers help ensure a special day for students, families and friends.

New research from David Gutmann, MD, PhD, may help doctors determine which medical issues are likely to manifest in patients with the inherited cancer syndrome neurofibromatosis type 1 (NF1). The findings indicate that varying mutations in the NF1 gene may lead to different clinical outcomes.

A study from the School of Medicine suggests that bacteriophages made of RNA – a close chemical cousin of DNA – likely play a much larger role in shaping the bacterial makeup of worldwide habitats than previously recognized.

New research from the School of Medicine indicates that much of that diabetes-related vision loss may result from nerve cell injury that occurs long before any blood vessels are damaged. The finding may lead to new approaches to treating it.

The Center for Diversity and Inclusion is accepting proposals for the inaugural Faculty Fellows & Emerging Scholar-Professional Program for the 2016-17 academic year.

From analyzing vast DNA sequences to handling electronic medical records, the importance of big data in medicine has increased dramatically in recent years. To support the growing need to manage and harness big data, the School of Medicine is launching an Institute for Informatics and has named Philip R.O. Payne its first director.

Patients with a rare, genetic form of diabetes often are misdiagnosed as having type 2 diabetes because the two share symptoms. But new research at the School of Medicine suggests that treating such patients with therapies designed for type 2 diabetes is potentially harmful and guidelines need to change.

New research at the School of Medicine indicates that initial levels of omega-3 fatty acids in a heart patient’s blood have a significant impact on whether that person will respond to omega-3 supplements to treat depression.